Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
MrktWatch
 
about-us our-services Trading-account ETrade MF IPO Research Fundamentals charts Market Watch News

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Profit and Loss
Aurobindo Pharma Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : M R Kumar
    Home        : Indian Private  Book Value: 406.2420157
    BSE Code  : 524804  Market Cap: 103395.41
    NSE Code  : AUROPHARMA  P / E              : 37.63 

Change Company :
(Rs in Cr.)
Profit and Loss
ParticularsMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Sales Turnover & Other Income 11759.2511261.4211315.748900.9211958.13
Excise Duty0.000.000.000.000.00
Total Income11712.7011329.0811431.979164.8711912.62
Raw Materials 5311.585675.345964.484755.955800.74
Stock Adjustments -46.5567.66116.23263.95-45.51
Other Manufacturing Expenses 421.52426.63414.51328.42705.68
Power & Fuel Cost174.82185.59191.58167.86477.99
Employee Cost 1161.151063.07980.56890.531600.04
Selling and Administration Expenses 873.42960.27822.21939.381009.36
Miscellaneous Expenses 108.12132.49164.49148.96249.13
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax3662.092885.692894.141933.772069.68
Interest & Financial Charges 213.15230.04182.6074.5816.94
Profit before Depreciation & Tax3448.942655.652711.541859.192052.74
Depreciation285.36297.20254.58243.26415.26
Profit Before Tax3163.582358.452456.961615.931637.48
Tax748.78611.66502.82388.82182.77
Profit After Tax2414.801746.791954.141227.111454.71
Adjustment below Net Profit 1.08-5.26-1.698.281.69
P & L Balance brought forward20090.4018348.8716660.0815864.1414671.41
Appropriations 232.300.00263.66439.45263.67
P & L Bal. carried down22273.9820090.4018348.8716660.0815864.14
Equity Dividend232.300.00263.66439.45263.67
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)400.000.00450.00750.00900.00
Earning Per Share (Rs.)41.5830.0833.3520.9424.83
Book Value391.14353.55336.62307.80292.15
Extraordinary Items -11.935.483.289.94-81.27
Top
BSE Disclaimer     |     Disclaimer     |     RA Disclosures and Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   ODR Circular   |   Attention Investors   | RA - Auditor Report 2025-2026   | RA – Annual Compliance Audit Report 2025-26   | RA – ATR   | UPI IDs for Payment

SEBI Saa₹thi Mobile App/SEBI Investor Website  

BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com
SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
Research Analyst SEBI Reg. No.INH000001527 | Research Analyst BSE Enlistment Number: 5104
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Designed, Developed, Maintained and Content Powered by
C-MOTS InfoTech(ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
Charts are powered by TradingView